Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 18201-18250 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06698601
Wild Blueberries in Colitis
NARecruiting
60 participants
Started: Sep 24, 2024 · Completed: Apr 30, 2027
2 conditions4 sponsors1 location
NCT06463119
Registry of Vaccine Responses in Immune Compromised Patients
N/ARecruiting
300 participants
Started: Sep 24, 2024 · Completed: Apr 30, 2029
1 condition1 sponsor1 location
NCT06678594
Implementation of a Standardized Algorithm for Coronary Calcification With Plaque Modification
N/ARecruiting
500 participants
Started: Sep 24, 2024 · Completed: Mar 23, 2027
3 conditions2 sponsors1 location
NCT06673797
Effects of Swiss Ball vs Frenkle Exercises on Static and Dynamic Balance in Ataxic CP
NARecruiting
18 participants
Started: Sep 24, 2024 · Completed: Dec 10, 2024
1 condition1 sponsor1 location
NCT06644664
Nicotine and Tobacco Message Framing to Change Smoking Behavior in Diverse Groups of Young Adult Smokers
NARecruiting
300 participants
Started: Sep 24, 2024 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT06569758
A Study of GenSci098 in Subjects With Active Thyroid Eye Disease
PHASE1Recruiting
76 participants
Started: Sep 24, 2024 · Completed: Dec 13, 2027
4 conditions1 sponsor1 location
NCT06577532
Study of KRAS Neoantigen mRNA Vaccine (ABO2102) in Patients With KRAS -Mutated Solid Tumors
EARLY_PHASE1Recruiting
56 participants
Started: Sep 24, 2024 · Completed: Aug 31, 2027
2 conditions2 sponsors1 location
NCT06618235
Trial of THEO-260 in Ovarian Cancer Patients
PHASE1/PHASE2Recruiting
28 participants
Started: Sep 24, 2024 · Completed: Jul 31, 2027
1 condition1 sponsor3 locations
NCT06458439
Epcoritamab-CAR T Cells for Large B-cell Lymphomas
PHASE2Recruiting
31 participants
Started: Sep 24, 2024 · Completed: Dec 31, 2027
5 conditions2 sponsors1 location
NCT05942716
Serotonin Control of Impulsivity in Tourette Disorder
PHASE2Recruiting
25 participants
Started: Sep 24, 2024 · Completed: Sep 24, 2028
1 condition1 sponsor2 locations
NCT06449677
Bionic Pancreas in CFRD
PHASE3Recruiting
150 participants
Started: Sep 24, 2024 · Completed: Mar 31, 2026
1 condition4 sponsors16 locations
NCT06623864
Significant Activities in the Integrated Person-centered Care Model
NARecruiting
10 participants
Started: Sep 24, 2024 · Completed: Jan 20, 2025
2 conditions1 sponsor1 location
NCT06341543
Quantiferon CMV to Identify Treatment Need for Asymptomatic CMV Infection After Solid Organ Transplant (QUANTIFOT)
NARecruiting
288 participants
Started: Sep 24, 2024 · Completed: Oct 31, 2026
5 conditions1 sponsor1 location
NCT06337136
neonAtal motoR paTtErn autoMatIc analySis
N/ARecruiting
1,000 participants
Started: Sep 24, 2024 · Completed: Jan 31, 2027
2 conditions1 sponsor1 location
NCT06650319
A Clinical Study to Evaluate the Safety and Efficacy of LY-M003 Injection in Patients With Wilson Disease
EARLY_PHASE1Recruiting
10 participants
Started: Sep 24, 2024 · Completed: Mar 30, 2030
1 condition1 sponsor1 location
NCT06574438
The Effectiveness of AIFIGA Program on Nursing Home Nursing Staff and Family and Residents'health
NARecruiting
210 participants
Started: Sep 24, 2024 · Completed: Jul 31, 2027
3 conditions1 sponsor1 location
NCT06614309
Non-invasive Treatment for Long COVID (Post COVID-19 Condition) Brain Fog
NARecruiting
45 participants
Started: Sep 24, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06252038
Rural Alliance for Diabetes Prevention
NARecruiting
160 participants
Started: Sep 24, 2024 · Completed: May 31, 2028
1 condition3 sponsors1 location
NCT06805487
Evaluation of the Protective Efficacy of TV003 or Previous Zika Infection Against Infection With ZIKV-SJRP Challenge Compared to DENV and ZIKV-naïve Controls Against Infection With ZIKV-SJRP Challenge
PHASE1Recruiting
26 participants
Started: Sep 24, 2024 · Completed: Sep 30, 2025
1 condition2 sponsors2 locations
NCT06608030
Effect of Esketamine on Perioperative Negative Mood in Patients Undergoing Cardiac Valve Surgery
NARecruiting
142 participants
Started: Sep 24, 2024 · Completed: Aug 30, 2025
3 conditions3 sponsors2 locations
NCT06398262
Alar SpO2 Sensor Study
N/ARecruiting
40 participants
Started: Sep 24, 2024 · Completed: Sep 30, 2025
4 conditions2 sponsors1 location
NCT06748248
Suspension Therapy Effects on Mobility and Balance in Down Syndrome
NARecruiting
26 participants
Started: Sep 24, 2024 · Completed: Jan 15, 2025
1 condition1 sponsor2 locations
NCT06776861
A Prospective, Multicenter, Observational Cohort Study Assessing the Efficacy and Safety of Radiotherapy-sensitized Immunotherapy in Advanced Breast Cancer
N/ARecruiting
150 participants
Started: Sep 24, 2024 · Completed: Sep 10, 2028
1 condition1 sponsor1 location
NCT06775275
A Study of Adebrelimab in Combination with Chemo with or Without Bevacizumab Neoadjuvant Therapy for Resectable NSCLC
PHASE2Recruiting
60 participants
Started: Sep 24, 2024 · Completed: Dec 31, 2029
1 condition1 sponsor1 location
NCT06504446
Study to Assess the Efficacy, Safety, and Tolerability of NOC-110 in Adults With Refractory or Unexplained Chronic Cough
PHASE2Recruiting
455 participants
Started: Sep 24, 2024 · Completed: Nov 10, 2025
1 condition2 sponsors102 locations
NCT07115134
Efficacy of a Novel Prototype Gastrostomy Tube Anchor Dressing
NARecruiting
75 participants
Started: Sep 24, 2024 · Completed: Dec 18, 2027
2 conditions1 sponsor1 location
NCT06589713
Effect of Renal Impairment on Enpatoran Pharmacokinetics
PHASE1Recruiting
40 participants
Started: Sep 24, 2024 · Completed: Apr 22, 2026
1 condition2 sponsors1 location
NCT06580275
The GLACE Study: Evaluating CLAAS With ICE Guided LAA Closure
NARecruiting
80 participants
Started: Sep 24, 2024 · Completed: Dec 31, 2025
2 conditions1 sponsor3 locations
NCT06700174
Lifetech AcuMark™ Sizing Balloon Post-Market Clinical Follow-up Study
N/ARecruiting
100 participants
Started: Sep 24, 2024 · Completed: Mar 31, 2025
1 condition1 sponsor5 locations
NCT06989099
Lymphedema Prevention Through Immediate Lymphatic Reconstruction (LILY) Trial.
PHASE2Recruiting
50 participants
Started: Sep 24, 2024 · Completed: Aug 1, 2029
1 condition1 sponsor1 location
NCT06603558
Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic Migraine
N/ARecruiting
3,000 participants
Started: Sep 24, 2024 · Completed: May 31, 2029
3 conditions1 sponsor4 locations
NCT06384079
Duration of Ureteral Rest Prior to Ureteral Reconstruction Surgery
N/ARecruiting
25 participants
Started: Sep 24, 2024 · Completed: Nov 30, 2030
1 condition1 sponsor1 location
NCT06362824
Promoting Physical Activity in Older Hispanic/Latino(a) Adults
NARecruiting
130 participants
Started: Sep 24, 2024 · Completed: May 31, 2027
3 conditions2 sponsors2 locations
NCT06474299
The Avenues Study: Dual Use Cessation
PHASE4Recruiting
500 participants
Started: Sep 24, 2024 · Completed: Jul 31, 2028
2 conditions2 sponsors1 location
NCT06493279
Evaluate the Safety and Efficacy of Intrathecal Injection of RJK002 in Patients With Amyotrophic Lateral Sclerosis
PHASE1Recruiting
9 participants
Started: Sep 24, 2024 · Completed: May 2, 2031
1 condition2 sponsors1 location
NCT06481891
A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy
PHASE3Recruiting
500 participants
Started: Sep 24, 2024 · Completed: Aug 31, 2026
2 conditions1 sponsor89 locations
NCT05687604
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
NARecruiting
1,500 participants
Started: Sep 24, 2024 · Completed: Jul 31, 2027
3 conditions1 sponsor1 location
NCT06601010
The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Pancreatic Cancer.
N/ARecruiting
30 participants
Started: Sep 24, 2024 · Completed: Aug 31, 2027
1 condition1 sponsor1 location
NCT06663007
RC48 Monotherapy or Combination With Envafolimab for CDK12 Alterations mCRPC With Standard Treatment Failure
PHASE1/PHASE2Recruiting
72 participants
Started: Sep 24, 2024 · Completed: Aug 31, 2027
2 conditions1 sponsor1 location
NCT06733948
ChemoRT With and Without Dental Stent for Taste Protection in NPC Patients
PHASE2Recruiting
50 participants
Started: Sep 24, 2024 · Completed: May 31, 2026
1 condition2 sponsors2 locations
NCT06581640
Chimeric Antigen Receptor Modified T Cells Targeting BCMA for the Treatment of Relapsed/Refractory Multiple Myeloma
PHASE2Recruiting
5 participants
Started: Sep 24, 2024 · Completed: Dec 31, 2028
2 conditions1 sponsor1 location
NCT06391034
Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer
PHASE2Recruiting
161 participants
Started: Sep 24, 2024 · Completed: Oct 31, 2032
1 condition2 sponsors1 location
NCT06614114
Albumin Bilirubin Index as a Predictor of Outcome of Variceal Bleeding
N/ARecruiting
48 participants
Started: Sep 24, 2024 · Completed: Dec 1, 2025
1 condition1 sponsor1 location
NCT06664411
Pola-ZR2P in Previously Untreated DLBCL
PHASE2Recruiting
80 participants
Started: Sep 24, 2024 · Completed: Dec 31, 2030
1 condition1 sponsor1 location
NCT06323889
Longitudinal Monitoring During Intermittent Fasting Protocols in Obese Adults
NARecruiting
90 participants
Started: Sep 23, 2024 · Completed: Jan 31, 2027
3 conditions1 sponsor1 location
NCT06706856
Quantitative Ultrasound to Assess Steatotic Liver Disease in Children
N/ARecruiting
120 participants
Started: Sep 23, 2024 · Completed: Jun 30, 2029
2 conditions4 sponsors1 location
NCT06796972
In Utero Surgery for Fetal Myelomeningocele: Decision-making Mechanisms and Psychological Impact of Prenatal Therapy
NARecruiting
44 participants
Started: Sep 23, 2024 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT06638593
MIRRORS-FROZEN - Comparing Open Vs Robotic Surgery in the Management of Women with Complex Pelvic Adnexal Masses ≤ 8cm.
NARecruiting
40 participants
Started: Sep 23, 2024 · Completed: Feb 1, 2027
7 conditions1 sponsor1 location
NCT06275919
Regorafenib for Recurrent Grade 2 and 3 Meningioma (MIRAGE Trial)
PHASE2Recruiting
104 participants
Started: Sep 23, 2024 · Completed: Mar 31, 2027
1 condition2 sponsors16 locations
NCT06439199
Biological, Prospective Study Evaluating the Dosage of Plasma Cytokines Including the FLT3 Ligand and IL6 of Patients Treated With Non-intensive Chemotherapy
N/ARecruiting
60 participants
Started: Sep 23, 2024 · Completed: Dec 15, 2026
3 conditions2 sponsors1 location